Biomarker identification in neurologic diseases: improving diagnostics and therapeutics (Q33202814)

23 July 2017

1 reference

title

Biomarker identification in neurologic diseases: improving diagnostics and therapeutics (English)

1 reference

23 July 2017

0 references

Keith D Coon

1

1 reference

23 July 2017

Travis Dunckley

series ordinal

2

1 reference

23 July 2017

Dietrich A Stephan

series ordinal

3

1 reference

23 July 2017

language of work or name

1 reference

1 May 2004

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

23 July 2017

published in

1 reference

23 July 2017

volume

4

1 reference

23 July 2017

issue

3

1 reference

23 July 2017

page(s)

361-375

1 reference

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

N-myc and c-myc expression in Alzheimer disease, Huntington disease and Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Banking for the future: an Australian experience in brain banking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

The experience of basic emotions in schizophrenia with and without affective negative symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Visualisation and quantification of rates of atrophy in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

A voxel-based morphometric MRI study in female patients with borderline personality disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Single-photon emission computed tomography (SPECT). Applications and potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Cerebral ventricular size and cognitive impairment in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Voxel-based morphometric analysis of gray matter in first episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Altered effective connectivity during working memory performance in schizophrenia: a study with fMRI and structural equation modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Excessive recruitment of neural systems subserving logical reasoning in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Prefrontal-posterior parietal networks in schizophrenia: primary dysfunctions and secondary compensations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Accurate and reproducible gene expression profiles from laser capture microdissection, transcript amplification, and high density oligonucleotide microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Laser capture microdissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

A gene expression atlas of the central nervous system based on bacterial artificial chromosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Killing the messenger: short RNAs that silence gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Short interfering RNA confers intracellular antiviral immunity in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Mechanisms of force loss in diabetic mouse skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Development of Autoimmune Exocrinopathy Resembling Sjögren's Syndrome in Estrogen-Deficient Mice of Healthy Background

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Purging of leukemia-contaminated bone marrow grafts using suicide adenoviral vectors: an in vivo murine experimental model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Early environment contributes to developmental disruption of MPFC after neonatal ventral hippocampal lesions in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Looking Backward to Move Forward: Early Detection of Neurodegenerative Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Alzheimer's disease: genotypes, phenotypes, and treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

In-vivo measurement of activated microglia in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

Historical aspects of the dichotomy between manic-depressive disorders and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.3.361

21 January 2018

Identifiers

DOI

10.1586/14737159.4.3.361

1 reference

23 July 2017

1 reference